Simon Cooper, M.B.B.S.

Simon Cooper, M.B.B.S.

Former Chief Medical OfficeratKeros Therapeutics· In proxies 2022–2024

Pay in FY2022Keros Therapeutics stock -17.9% the same year

Simon Cooper, M.B.B.S. was paid $2.3M in FY2022 (Dec). Keros Therapeutics stock fell 17.9% that year.

Pay$100 in the stock at the end of FY21 → $82
Pay is from the Summary Compensation Table of each Keros Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Keros TherapeuticsPublic company · 4 yr
    • Former Chief Medical Officer2022 – Present · 4 yrStock in role -80%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?